The purpose of RICB is focused primarily on providing services in the field of science and research. One concomitant activity is implementing these results in relation to pilot trials, respectively their application in question along with results in practice. Our company offers services in the field of proteomics, metabolomics, the synthesis of recombinant proteins, biotechnology, clinical detection systems and bioinformatics.
RICB develops and manufactures a modern high-tech medical device for oncomarker detection in blood in very non- invasive ways.
RICB offers broad-spectrum services: the development and research of recombinant proteins, the modification of nanosurfaces, the design and implementation of electronic high-tech equipment, especially for use in medicine and life science, as well as the work of other biotechnological and biomechatronic processes.
In RICB, our team also deals with the production and optimization of recombinant protein production, including cell line preparation, separation and purification of the resulting proteins, focusing on the highest yield, purity and quality of the obtained product.